Ken Griffin Tiziana Life Sciences LTD Call Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding TLSA
# of Institutions
27Shares Held
929KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA220KShares$210,7400.0% of portfolio
-
Hsbc Holdings PLC London, X0125KShares$120,3500.0% of portfolio
-
Morgan Stanley New York, NY111KShares$106,0950.0% of portfolio
-
Zhang Financial LLC55.9KShares$53,6510.0% of portfolio
-
Ausdal Financial Partners, Inc. Davenport, IA55.7KShares$53,4720.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $98.2M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...